Advances in the Drugs Treatment of Psoriatic Arthritis
Psoriatic arthritis (PsA), an inflammatory articular disease closely associated with psoriasis, is characterized by a wide range of symptoms including skin lesion, peripheral and axial joint involvement, enthesitis, and dactylitis. In recent years, significant advancements have been made in the trea...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Medical Journal of Peking Union Medical College Hospital
2024-12-01
|
| Series: | Xiehe Yixue Zazhi |
| Subjects: | |
| Online Access: | https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2024-0820 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823865197342752768 |
|---|---|
| author | LU Chaofan LENG Xiaomei |
| author_facet | LU Chaofan LENG Xiaomei |
| author_sort | LU Chaofan |
| collection | DOAJ |
| description | Psoriatic arthritis (PsA), an inflammatory articular disease closely associated with psoriasis, is characterized by a wide range of symptoms including skin lesion, peripheral and axial joint involvement, enthesitis, and dactylitis. In recent years, significant advancements have been made in the treatment of PsA, promoting continuous improvement in patient outcomes. This article aims to comprehensively review the current status of drug treatment for PsA, encompassing not only new clinical evidence for conventional synthetic disease-modifying antirheumatic drugs(csDMARDs) but also an in-depth exploration of biologics or targeted synthetic disease-modifying antirheumatic drugs(tsDMARDs) against various targets in recent years. The objective of this study is to enhance clinicians' understanding of treatment strategies for PsA and provide more precise and effective treatment options for patients. |
| format | Article |
| id | doaj-art-19ba6e84f2d14bd6b980bf419fc4b453 |
| institution | Kabale University |
| issn | 1674-9081 |
| language | zho |
| publishDate | 2024-12-01 |
| publisher | Editorial Office of Medical Journal of Peking Union Medical College Hospital |
| record_format | Article |
| series | Xiehe Yixue Zazhi |
| spelling | doaj-art-19ba6e84f2d14bd6b980bf419fc4b4532025-02-08T07:47:34ZzhoEditorial Office of Medical Journal of Peking Union Medical College HospitalXiehe Yixue Zazhi1674-90812024-12-01161657410.12290/xhyxzz.2024-0820Advances in the Drugs Treatment of Psoriatic ArthritisLU Chaofan0LENG Xiaomei1Department of Rheumatology, Key Laboratory of Rheumatology, Ministry of Education, National Clinical Research Center for Dermatologic and Immunologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, ChinaDepartment of Rheumatology, Key Laboratory of Rheumatology, Ministry of Education, National Clinical Research Center for Dermatologic and Immunologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, ChinaPsoriatic arthritis (PsA), an inflammatory articular disease closely associated with psoriasis, is characterized by a wide range of symptoms including skin lesion, peripheral and axial joint involvement, enthesitis, and dactylitis. In recent years, significant advancements have been made in the treatment of PsA, promoting continuous improvement in patient outcomes. This article aims to comprehensively review the current status of drug treatment for PsA, encompassing not only new clinical evidence for conventional synthetic disease-modifying antirheumatic drugs(csDMARDs) but also an in-depth exploration of biologics or targeted synthetic disease-modifying antirheumatic drugs(tsDMARDs) against various targets in recent years. The objective of this study is to enhance clinicians' understanding of treatment strategies for PsA and provide more precise and effective treatment options for patients.https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2024-0820psoriatic arthritisconventional synthetic disease-modifying antirheumatic drugsbiologicstargeted synthetic disease-modifying antirheumatic drugs |
| spellingShingle | LU Chaofan LENG Xiaomei Advances in the Drugs Treatment of Psoriatic Arthritis Xiehe Yixue Zazhi psoriatic arthritis conventional synthetic disease-modifying antirheumatic drugs biologics targeted synthetic disease-modifying antirheumatic drugs |
| title | Advances in the Drugs Treatment of Psoriatic Arthritis |
| title_full | Advances in the Drugs Treatment of Psoriatic Arthritis |
| title_fullStr | Advances in the Drugs Treatment of Psoriatic Arthritis |
| title_full_unstemmed | Advances in the Drugs Treatment of Psoriatic Arthritis |
| title_short | Advances in the Drugs Treatment of Psoriatic Arthritis |
| title_sort | advances in the drugs treatment of psoriatic arthritis |
| topic | psoriatic arthritis conventional synthetic disease-modifying antirheumatic drugs biologics targeted synthetic disease-modifying antirheumatic drugs |
| url | https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2024-0820 |
| work_keys_str_mv | AT luchaofan advancesinthedrugstreatmentofpsoriaticarthritis AT lengxiaomei advancesinthedrugstreatmentofpsoriaticarthritis |